Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). [electronic resource]
Producer: 20180810Description: 578-585 p. digitalISSN:- 1865-3774
- Adult
- Aged
- Allografts
- Benzoates -- administration & dosage
- Deferasirox
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Iron Chelating Agents -- administration & dosage
- Iron Overload -- drug therapy
- Male
- Middle Aged
- Time Factors
- Treatment Outcome
- Triazoles -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.